<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                   FORM 10-QSB

[X]  Quarterly  Report  pursuant  to  Section  13  or 15(d) of the Securities
     Exchange  Act  of  1934

     For  the  quarterly  period  ended  March  31,  2002

[ ]  Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act
     of  1934

     For  the  transition  period  from          to

Commission  File  Number  001-14297
                          ---------

                                MW Medical, Inc.
                                ----------------
        (Exact name of Small Business Issuer as specified in its charter)

Nevada                                               86-0907471
-------------------------------                      --------------------
(State or other jurisdiction of                      (IRS  Employer
incorporation  )                                     Identification  No.)

                  6929 E. Cheney Paradise Valley, Arizona 85253
                  ---------------------------------------------
                    (Address of principal executive offices)

                                 (480) 315-8600
                                 --------------
                 Issuer's telephone number, including area code


State the number of shares outstanding of each of the issuer's classes of common
equity,  as  of  the  last  practicable  date.

            Class                               Outstanding as March 31, 2002
------------------------------------           ---------------------------------
$.001 par value Class A Common Stock                   24,550,070 shares

Transitional  Small  Business Disclosure Format (Check one): Yes [   ] No [ X  ]


<PAGE>

                         PART I - FINANCIAL INFORMATION

Item  1.      Financial  Statements.

BASIS  OF  PRESENTATION

General

The accompanying unaudited financial statements have been prepared in accordance
with  the  instructions  to  Form  10-QSB  and,  therefore,  do  not include all
information  and  footnotes  necessary  for a complete presentation of financial
position,  results  of  operations,  cash  flows,  and  stockholders'  equity in
conformity  with  generally  accepted  accounting principles.  In the opinion of
management,  all adjustments considered necessary for a fair presentation of the
results  of  operations  and  financial position have been included and all such
adjustments  are  of a normal recurring nature.  Operating results for the three
months  ended March 31, 2002, are not necessarily indicative of the results that
can  be  expected  for  the  year  ending  December  31,  2002



                                       2

<PAGE>


                                MW Medical, Inc.

                          CONSOLIDATED  BALANCE  SHEETS


CURRENT ASSETS
  Cash                                                    $        128
  Accounts Receivable
  Inventory                                                    300,000
  Deposits                                                           -
  Other current assets
                                                          -------------
          Total current assets                                 300,128

INVENTORY, long-term

PROPERTY AND EQUIPMENT, net                                     46,251

OTHER RECEIVABLES, net
                                                          -------------
                                                          $    346,379
                                                          =============

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
  Accounts payable                                        $    255,956
  Accrued expenses                                             614,446
  Note payable - related party                                 631,421
                                                          -------------
          Total current liabilities                          1,501,823

COMMITMENTS AND CONTINGENCIES                                        -

STOCKHOLDERS' EQUITY
  Common stock $.001 par value; authorized - 100,000,000
    shares issued and outstanding, 24,517,443                   24,517
  Additional paid-in capital                                13,687,857
  Note receivable from former parent
  Accumulated deficit                                      (14,867,818)
                                                          -------------
          Total stockholders' equity                        (1,155,444)
                                                          -------------
                                                          $    346,379
                                                          -------------

                                       3

<PAGE>

                                MW Medical, Inc.

                   CONSOLIDATED  STATEMENTS  OF  OPERATIONS
                                   (Unaudited)


                                                  Three months ended March 31,
                                                  ----------------------------
                                                       2002          2001
                                                  -------------  -------------
Sales, net                                        $          -   $   110,060
Cost of sales                                                -        71,056
                                                  -------------  -------------
                                                             -        39,004

General and administrative expenses                    117,007       219,402
Depreciation and amortization                            9,677        36,978
Research and development                                 1,000       126,934
                                                  -------------  -------------
          Total operating expenses                     127,684       383,314

          Net operating loss                          (127,684)     (344,310)


Interest income (expense)                              (15,542)     (214,068)
                                                  -------------  -------------
          NET LOSS                                $   (143,226)  $  (558,378)
                                                  =============  =============

Net loss per weighted average share               $      (0.01)  $     (0.03)
                                                  =============  =============

Weighted average number of common shares used to
  compute net loss per weighted average share       24,517,443    21,292,443
                                                  -------------  -------------


                                       4

<PAGE>

                                    MW Medical, Inc.

                            CONSOLIDATED STATEMENTS OF CASH FLOWS
                                         (Unaudited)


                                                          For the Three Months
                                                             ended March 31,
                                                            2002        2001
                                                        ------------ -----------
Cash flows from operating activities
  Net Loss                                              $ (143,226)  $ (558,378)
  Adjustments to reconcile net loss to cash used in
    operating activities:
      Depreciation and amortization                          9,677       36,638
      Deferred salaries                                     88,037       78,624
      Interest expense                                      15,542      214,068
      Changes in assets and liabilities
        Increase in accounts receivable                                 (71,516)
        Decrease (increase) in inventories                               48,653
        Decrease (increase) in restricted cash                   -            -
        Decrease (increase) in prepaid expenses
          and other receivables                                  -          (89)
        Increase in accounts payable and accrued
          expenses                                          14,339      (45,479)
        Increase in deposits                                     -            -
                                                        ------------ -----------
          Net cash used in operating activities            (15,631)    (297,479)

Cash flows used in investing activities

  Purchase of equipment                                          -



                                        5


<PAGE>

                                MW Medical, Inc.

                CONSOLIDATED STATEMENTS OF CASH FLOWS - Continued
                                   (Unaudited)



                                                          For the Three Months
                                                              ended March 31,
                                                              2002      2001
                                                          ----------  ---------
Cash flows from financing activities
  Proceeds from line of credit                                    -          -
  Proceeds from loans                                        15,550    289,100
  Payments on loans                                               -          -
  Proceeds from the exercise of stock options                     -          -
  Sale of common stock                                            -          -
                                                          ----------  ---------

          Net cash provided by financing activities          15,550    289,100
                                                          ----------  ---------

          (Decrease) increase in cash and cash
           equivalents                                          (81)    (8,379)

Cash and cash equivalents at beginning of period                209      9,825
                                                          ----------  ---------

Cash and cash equivalents at end of period                $     128   $  1,446
                                                          ==========  =========

Supplemental information
  Cash paid for interest                                  $       -
  Cash paid for income taxes                                          $  2,400



                                       6

<PAGE>

                                MW Medical, Inc.

                    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                             March 31, 2002 (Unaudited)


NOTE  A  -  SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

Basis  of  presentation
-----------------------

The  accompanying  consolidated  financial  statements  have  been  prepared  in
accordance  with  generally  accepted accounting principles ("GAAP") for interim
financial information and with the instructions to Form 10QSB. Accordingly, they
do  not  include  all  of  the  information  and footnotes required by generally
accepted  auditing  principles  for complete financial statements. The unaudited
consolidated  financial  statements  and  notes  should,  therefore,  be read in
conjunction with the financial statements and notes thereto in the Annual Report
on  Form  10-KSB  for  the  year  ended  December  31,  2001.  In the opinion of
management,  all  adjustments  (consisting  of normal and recurring adjustments)
considered  necessary  for a fair presentation, have been included.  The results
of  operations  for  the  three-month  period  ended  March  31,  2002  are  not
necessarily indicative of the results that may be expected for the entire fiscal
year  2002.


NOTE  B  -  REALIZATION  OF  ASSETS

The  Company  has suffered recurring losses from operations and will continue to
incur losses for the foreseeable future due to the significant costs anticipated
to  be incurred in connection with manufacturing, marketing and distributing its
microwave  products.  In  addition,  the  Company intends to continue to conduct
research  and  development  activities,  including  regulatory  submittals  and
clinical  trials  to  develop  additional  applications  for its technology. The
Company  operates  in  a highly competitive environment and is subject to all of
the  risks  inherent  in  a  new  business  enterprise.

In view of the matters described in the preceding paragraph, recoverability of a
major  portion  of  the recorded asset amounts shown in the accompanying balance
sheet  is  dependent  upon continued operations of the Company, which in turn is
dependent  upon  the  Company's  ability to meet its financing requirements on a
continuing  basis,  to  maintain present financing, and to succeed in its future
operations.  The financial statements do not include any adjustments relating to
the  recoverability  and classification of recorded asset amounts or amounts and
classification  of  liabilities  that  might  be necessary should the Company be
unable  to  continue  in  existence.


                                       7

<PAGE>

                                MW Medical, Inc.

               NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

                             March 31, 2002 (Unaudited)


NOTE  B  -  REALIZATION  OF  ASSETS  -  Continued


Management  has  taken  the following steps, which it believes are sufficient to
provide  the  Company  with the ability to continue its operations over the near
term:  The Company has reduced staffing to key personnel, specifically corporate
officers  and  technicians  necessary  to  continue  manufacturing  operations.
Additionally,  all  officers  are voluntarily participating in a salary deferral
program  until  additional  funding  is  secured. The Company has also initiated
talks  with  several  of  its  larger  vendors to obtain extended payment terms.
While  the  Company  has been successful in negotiating payment terms with a few
vendors, formal agreements have not been established with all of the vendors and
there can be no guarantee such agreements will ever be reached.  Sales of the MW
2000  are  expected  to  at  least partially offset the cash requirements of the
business.  The  Company  is  pursuing  opportunities  to  establish  a strategic
alliance  with  an  established entity or to possibly be acquired or merged with
another  entity.  However,  there  can  be no assurance that the Company will be
able  to  complete  any contemplated alliance, merger or sale transaction within
the  required  time  frame.



                                       8

<PAGE>

Item  2.     Management's  Discussion  and  Analysis  of Financial Condition and
Results  of  Operations.

As  of January 22, 2002, we have filed a Petition for relief under Chapter 11 of
the  Bankruptcy  Code.  An  automatic  stay  is  now in place.  We will use this
bankruptcy  to  protect  the business from our creditors while we reorganize and
try  to  work  out  a  plan  to pay our debts.  The Petition was filed in United
States  Bankruptcy Court, District of Arizona, In Re: MW MEDICAL, INC., a Nevada
Corporation,  Case  No.  02-0108-90-PHX-RTB,  and  In  Re:  MICROWAVE  MEDICAL
CORPORATION,  a California Corporation, Case No. 02-01298-PHX-GBN.  The location
of  the  United  States  Trustee  is 2929 N. Central Avenue, Suite 700, P.O. Box
36170,  Phoenix,  Arizona  85067-6170,  (602)  640-2100.

In  the  past year, sales have been slower than anticipated.  Our small revenues
have  been greatly outpaced by our operating expenses, and we are now insolvent.
With  the  economic  downturn, our unproven ability to generate revenues and the
economic  fallout  from the events of September 11, 2001, we have been unable to
raise additional capital.  Our secured creditor has determined that the value of
the  collateral  and  the  growing unsecured debt made it unlikely that we could
raise  additional  capital.  Without  any  further  loans available, and with no
prospect of raising additional capital in the face of our current balance sheet,
we  are unable to continue in business without the aid of Chapter 11 protection.
Even  with the protection afforded by the bankruptcy petition, we cannot provide
investors  with  any  assurance  we  will  emerge  from  bankruptcy  as a viable
business.

There  are  no  assets  to  be  distributed  to creditors or shareholders as the
secured  creditor  has  a  lien  on all assets and is undersecured.  The primary
objective  of  this  reorganization  is  to  allow  us to go forward as a public
company  free  of  all  debt  and  with  a  reduced secured debt.  The plan also
provides for payment to unsecured creditors of more than they would receive in a
liquidation.  We  can then seek business opportunities for a reverse merger that
will  allow  creditors and shareholders to realize value not otherwise available
to  them.  In  the  event  of  an inability to raise capital and the loss of its
assets,  we will still have the capacity to seek a reverse merger partner but we
cannot  assure  investors  a  reverse  merger  partner  will  be  found.

Since  the  filing  of the Bankruptcy, the company has not been actively selling
any  machines.  A  plan  of  organization  has been filed with the court and all
ballots  from  creditors  are  expected  to  be  counted  on  May  22,  2002.

Assets

Total  assets  decreased  to  $  346,379  on  March  31, 2002 from $356,137 from
December  31,  2001,  a  decrease  of  $9,758  or 2.7%.  The net change resulted
primarily  from  a  decrease  in  value  of  ourequipment.

Liabilities  And  Stockholders'  Equity

Our  liabilities  increased  by $133,468, or 9.8% to $ 1,501,823 as of March 31,
2002.  The increase in liabilities was caused by unpaid salary and notes payable
-  related  party.  All  cost  involved  in the filing of the bankruptcy and the
continued  operations  of  the Company is still being funded by Ms. Wallace, our
president  and  chief  executive  officer.  These amounts are


                                       9

<PAGE>

reflected  in  notes  payable  - related party. The officers of the company have
elected  to  defer  all  of  their salaries. Stockholders' equity decreased to a
deficit  of  $1,155,444  from $1,01,218 as of December 31, 2001. The decrease in
stockholders'  equity  resulted  from  the  net  loss  from  operations.


Results  of  Operations

Due  to  the  lack of funding and the filing of Chapter 11, Bankruptcy code, the
operations  of  the Company have consisted of planning for the reorganization of
the  Company

Net  loss  for  the  three  months ended March 31, 2002 was $143,226 compared to
$558,378  on  March  31,  2001.  This decrease in the net loss was caused by our
scaling  back  of  operations,  including  a  reduction in employees, closing of
certain  clinical  sites,  and  a  slow  down  in research and development work.

General  and  administrative  expenses for the three months ended March 31, 2002
was  $117,007  compared to $219,402 for the same period in 2001. This reflects a
decrease  of  $102,395 or 46.7%.  This decrease was primarily due to significant
reductions  in  staff  and  all  operating  expenses.

Research  and  development expenses were $1,000 for the three months ended March
31,  2002  compared  to  $126,934  for the same period in 2001.  The decrease of
reflects  the  cessation  of  all  clinical  sites,

Depreciation and amortization expenses for the three months ended March 31, 2002
were  $9,677  compared  to  $36,978  for  the  same period in 2001. In 2001, the
Company  wrote  down the value of its inventory.  We also wrote off the value of
all  machines  used  in  the  clinical  sites  for  research  and  development.

Liquidity  and  Capital  Resources

We  have  extremely limited cash resources to sustain operations.  While limited
funds  have  been  generated  from  revenues, it is unlikely cash generated from
operations  will  be  sufficient  to  continue  operations.

For  the  first  quarter  of  2002, we have relied upon Ms. Wallace to providing
funding.  In  fact,  Ms.  Wallace funded all operations since November 2000.  We
have  not  yet  identified  new  sources  for  financing and we are currently in
default  on  our  notes  to  Ms.  Wallace.

As  of  March  31,  2002,  the  Company  had  $128  in  cash.

We  used  cash  of  $15,631  in our operating activities during the three months
ending  March  31, 2002 compared to $297,479 for the same period in 2001. In the
first  quarter  of  2002,  we  were  primarily  involved  in  procedures for the
bankruptcy.  The  Company  did  not  have  any  funds  for  operations.


                                       10

<PAGE>

Forward-Looking  Statements

Many  statements made in this report are forward-looking statements that are not
based  on  historical  facts.  Because  these forward-looking statements involve
risks  and  uncertainties,  there  are important factors that could cause actual
results  to  differ  materially  from  those  expressed  or  implied  by  these
forward-looking  statements.  The forward-looking statements made in this report
relate  only  to  events  as  of  the  date  on  which  the statements are made.




                                       11

<PAGE>

                           PART II - OTHER INFORMATION


Item  1.          Legal  Proceedings:

None

Item  2.     Changes  in  Securities  and  Use  of  Proceeds:

None

Item  3.     Defaults  Upon  Senior  Securities:

None

Item  4.     Submission  of  Matters  to  a  Vote  of  Security  Holders:

None

Item  5.     Other  Information:

None

Item  6.  Exhibits  and  Reports  on  Form  8-K:

         (a)     Exhibits
None
         (b)     Reports  on  Form  8-K

          A  form  8-K  was  filed on January 11, 2002 to announce the Company's
          intent  to file for bankruptcy. The 8-K also announced the resignation
          of three members of the Board of Directors, Elliot Smith, Nigel Parker
          and  Neil  Marcus,  who  had  resigned  on  December  30,  2001.



                                       12

<PAGE>

                                   SIGNATURES

In  accordance  with  the  requirements  of the Exchange Act, the registrant has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                                        MW  Medical,  Inc.


DATED:     May 20, 2002                 /s/ Grace Sim
                                        ____________________________________
                                        Grace Sim, Chief Financial Officer



                                       13